JUVÉDERM® ULTRA/ULTRAPLUS XC

JUVÉDERM^® ULTRA/ULTRAPLUS XC

JUVÉDERM^® ULTRA/ULTRAPLUS XC are versatile products for lines and folds. You may have had thin lips since birth.  Ordinarily, a gradual reduction in volume happens over time as collagen breaks down faster than it is replaced. Patients who want a fuller, plumper look can choose the Ultra version of this dermal filler to add noticeable volume to their smile. Ultra is an option for perioral lines also.

• Juvéderm® (Volbella, Ultra/UltraPlus, Vollure, Voluma, Volux): Treat yourself to $75 off of one 1ml syringe with this ALLĒ fall offer.
• NEW! SkinVive injectable microdroplet skin hydrator by Juvéderm: $650 for two syringes.

UltraPlus is more resilient and is better deployed at the mouth corner’s downturns, marionette’s lines and other areas of volume loss.

In our experience results (after full correction) last up to 6 months for Ultra, and 9-12 months with UltraPlus.

JUVÉDERM® ULTRA/ULTRAPLUS XC are crystal-clear gels. Injection is through an ultra-fine needle. The lidocaine inside the gel improves comfort during the injection. Besides helping restore volume beneath the surface of different areas of the face without surgery, treatment additionally boosts the skin’s resilience. Both come in 1.0 as well as 0.55cc syringes.

WHAT IS HYALURONIC ACID?

Hyaluronic acid, or HA, is a natural substance in the body that strongly binds to water. As a result it delivers volume and added resilience to the skin. Modified HA is the main ingredient behind JUVÉDERM ^®. The physical properties are different between formulations. This allows selection of the optimal match for the problem at hand. JUVÉDERM VOLBELLA ^® XC is the softest version, VOLUMA ^® the firmest (think chin and cheeks), while VOLLURE ^® has the most pliability (laugh-lines).

Our practice  has educational displays that patients can interact with to experience what these different versions look and feel like.

Treatment  as a rule is done in under 15 minutes. A temporary brief stinging sensation is generally well tolerated. Afterwards side effects can be in the form of some tenderness, swelling, firmness, lumps/bumps. Bruising, redness, discoloration, and itching can occur as well. Side effects are transient and mild or moderate in discomfort . They generally last under 30 days. Juvéderm can reversed with Hyaluronidase.

Which Juvéderm^® is for you?

A complimentary consultation with Dr. Robben will address your concerns and review the procedure and possible side effects.

[includeme file=”includes/subpage-cta-fb2.php”]

There are ways to save on the cost of treatment. Patients want to keep away their forehead lines, crow’s feet, and other wrinkles, so we offer long-term cost-savings: the Mind Your Skin Maintenance Program. Maximize safe, reliable results that help you keep looking your best by scheduling injection sessions at regular intervals. In addition, MindYourSkin and Dr. Robben partner with Allergan, the makers of BOTOX^® and Juvederm^®.

Go to www.Alle.com and migrate your account (new patients can start one there) that also works for Botox^®, Kybella^®and Latisse, as well as various in-office treatments such as laser hair removal, dermabrasion, Ultrashape and more…

is now

IN THE NEWS

COVID-19 update. Delayed dermal filler inflammatory events very rarely occur with both hyaluronic acid and non-hyaluronic acid fillers. Evidence suggests these reactions can be immunologically triggered by viral and bacterial illness, vaccinations such as the influenza vaccine, and dental procedures. These rare adverse events are temporary and respond to treatments such as oral corticosteroids and hyaluronidase, and often resolve without treatment. Given currently available data, patients already treated with dermal fillers should not be discouraged or precluded from receiving vaccines of any kind. Similarly, patients who have had vaccines should not be precluded from receiving dermal fillers in the future. Specifically, with regard to the Moderna mRNA-1273 trial, there were a total of 3 reactions possibly related to dermal fillers out of 15,184 vaccine recipients. It is unknown how many subjects in the trial had previous treatment with dermal fillers.

Check for Specials